vs

Side-by-side financial comparison of INTELLINETICS, INC. (INLX) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.

Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $4.3M, roughly 1.6× INTELLINETICS, INC.). Precipio, Inc. runs the higher net margin — 7.7% vs -4.8%, a 12.5% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs 1.0%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-550.4K). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -2.1%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

INLX vs PRPO — Head-to-Head

Bigger by revenue
PRPO
PRPO
1.6× larger
PRPO
$6.8M
$4.3M
INLX
Growing faster (revenue YoY)
PRPO
PRPO
+27.4% gap
PRPO
28.4%
1.0%
INLX
Higher net margin
PRPO
PRPO
12.5% more per $
PRPO
7.7%
-4.8%
INLX
More free cash flow
PRPO
PRPO
$841.4K more FCF
PRPO
$291.0K
$-550.4K
INLX
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-2.1%
INLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INLX
INLX
PRPO
PRPO
Revenue
$4.3M
$6.8M
Net Profit
$-208.0K
$526.0K
Gross Margin
64.5%
45.9%
Operating Margin
-5.0%
7.9%
Net Margin
-4.8%
7.7%
Revenue YoY
1.0%
28.4%
Net Profit YoY
-287.3%
244.1%
EPS (diluted)
$-0.06
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INLX
INLX
PRPO
PRPO
Q4 25
$4.3M
$6.8M
Q3 25
$4.0M
$6.9M
Q2 25
$4.0M
$5.6M
Q1 25
$4.2M
$4.9M
Q4 24
$4.3M
$5.3M
Q3 24
$4.6M
$5.3M
Q2 24
$4.6M
$4.5M
Q1 24
$4.5M
$3.5M
Net Profit
INLX
INLX
PRPO
PRPO
Q4 25
$-208.0K
$526.0K
Q3 25
$-369.8K
$-79.0K
Q2 25
$-567.6K
$74.0K
Q1 25
$-727.6K
$-884.0K
Q4 24
$-53.7K
$-365.0K
Q3 24
$-392.9K
$-626.0K
Q2 24
$75.0K
$-1.2M
Q1 24
$-174.7K
$-2.1M
Gross Margin
INLX
INLX
PRPO
PRPO
Q4 25
64.5%
45.9%
Q3 25
64.2%
43.6%
Q2 25
68.0%
43.2%
Q1 25
67.6%
43.6%
Q4 24
63.5%
49.8%
Q3 24
59.8%
43.1%
Q2 24
64.7%
38.1%
Q1 24
64.3%
26.5%
Operating Margin
INLX
INLX
PRPO
PRPO
Q4 25
-5.0%
7.9%
Q3 25
-9.5%
-0.9%
Q2 25
-12.7%
-14.6%
Q1 25
-16.1%
-17.5%
Q4 24
-0.3%
-6.3%
Q3 24
-6.5%
-11.3%
Q2 24
3.7%
-26.8%
Q1 24
-0.8%
-59.6%
Net Margin
INLX
INLX
PRPO
PRPO
Q4 25
-4.8%
7.7%
Q3 25
-9.2%
-1.1%
Q2 25
-14.2%
1.3%
Q1 25
-17.1%
-18.0%
Q4 24
-1.3%
-6.9%
Q3 24
-8.6%
-11.9%
Q2 24
1.6%
-27.1%
Q1 24
-3.9%
-59.8%
EPS (diluted)
INLX
INLX
PRPO
PRPO
Q4 25
$-0.06
$0.36
Q3 25
$-0.08
$-0.05
Q2 25
$-0.13
$0.05
Q1 25
$-0.17
$-0.59
Q4 24
$-0.02
$-0.22
Q3 24
$-0.09
$-0.42
Q2 24
$0.02
$-0.83
Q1 24
$-0.04
$-1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INLX
INLX
PRPO
PRPO
Cash + ST InvestmentsLiquidity on hand
$2.7M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$11.4M
$14.6M
Total Assets
$17.3M
$21.3M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INLX
INLX
PRPO
PRPO
Q4 25
$2.7M
Q3 25
$2.3M
Q2 25
$2.1M
$1.1M
Q1 25
$2.1M
$1.0M
Q4 24
$2.5M
$1.4M
Q3 24
$2.5M
$1.1M
Q2 24
$1.7M
$1.3M
Q1 24
$1.2M
$776.0K
Total Debt
INLX
INLX
PRPO
PRPO
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INLX
INLX
PRPO
PRPO
Q4 25
$11.4M
$14.6M
Q3 25
$11.4M
$13.7M
Q2 25
$11.6M
$12.3M
Q1 25
$10.4M
$11.7M
Q4 24
$10.6M
$12.1M
Q3 24
$10.4M
$11.9M
Q2 24
$10.3M
$12.1M
Q1 24
$10.0M
$12.8M
Total Assets
INLX
INLX
PRPO
PRPO
Q4 25
$17.3M
$21.3M
Q3 25
$18.0M
$21.2M
Q2 25
$17.2M
$18.8M
Q1 25
$18.0M
$17.8M
Q4 24
$18.6M
$17.0M
Q3 24
$19.0M
$17.0M
Q2 24
$18.9M
$17.3M
Q1 24
$18.9M
$16.6M
Debt / Equity
INLX
INLX
PRPO
PRPO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INLX
INLX
PRPO
PRPO
Operating Cash FlowLast quarter
$-529.8K
$366.0K
Free Cash FlowOCF − Capex
$-550.4K
$291.0K
FCF MarginFCF / Revenue
-12.7%
4.3%
Capex IntensityCapex / Revenue
0.5%
1.1%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$579.5K
$359.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INLX
INLX
PRPO
PRPO
Q4 25
$-529.8K
$366.0K
Q3 25
$1.4M
$10.0K
Q2 25
$222.9K
$353.0K
Q1 25
$-110.4K
$-44.0K
Q4 24
$136.2K
$565.0K
Q3 24
$1.9M
$41.0K
Q2 24
$1.2M
$500.0K
Q1 24
$611.8K
$-667.0K
Free Cash Flow
INLX
INLX
PRPO
PRPO
Q4 25
$-550.4K
$291.0K
Q3 25
$1.3M
$-44.0K
Q2 25
$81.2K
$294.0K
Q1 25
$-231.4K
$-182.0K
Q4 24
$90.0K
Q3 24
$1.7M
$-68.0K
Q2 24
$994.2K
Q1 24
$593.5K
FCF Margin
INLX
INLX
PRPO
PRPO
Q4 25
-12.7%
4.3%
Q3 25
32.0%
-0.6%
Q2 25
2.0%
5.2%
Q1 25
-5.4%
-3.7%
Q4 24
2.1%
Q3 24
37.9%
-1.3%
Q2 24
21.4%
Q1 24
13.2%
Capex Intensity
INLX
INLX
PRPO
PRPO
Q4 25
0.5%
1.1%
Q3 25
1.8%
0.8%
Q2 25
3.5%
1.0%
Q1 25
2.9%
2.8%
Q4 24
1.1%
Q3 24
4.2%
2.1%
Q2 24
3.9%
Q1 24
0.4%
Cash Conversion
INLX
INLX
PRPO
PRPO
Q4 25
0.70×
Q3 25
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
15.68×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons